Evidence map›Paper›PMID 34290522›Full record

ReviewInternational journal of general medicine2021

Recent Insights into the Management of Pleural Infection.

Maged Hassan, Shefaly Patel, Ahmed S Sadaka, Eihab O Bedawi, John P Corcoran, José M Porcel

Open access · goldAbstract readReview
In one paragraph

Review in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Pleural fluid biomarkers: a narrative review.Journal of thoracic disease · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. The ShortERJ open research · 2023
    Article
  16. Pleural Space Infections.Life (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Maged HassanChest Diseases Department, Alexandria University Faculty of Medicine, Alexandria, Egypt.ORCID 0000-0002-8768-6548
Shefaly PatelOxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK.
Ahmed S SadakaChest Diseases Department, Alexandria University Faculty of Medicine, Alexandria, Egypt.
Eihab O BedawiOxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK.
John P CorcoranDepartment of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, UK.
José M PorcelDepartment of Internal Medicine, Arnau de Vilanova University Hospital, Lleida, Spain.ORCID 0000-0002-2734-8061
Alexandria University · EGOxford University Hospitals NHS Trust · GBHospital Universitari Arnau de Vilanova · ESUniversity Hospitals Plymouth NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleural infection in adults has considerable morbidity and continues to be a life-threatening condition. The term "pleural infection" encompasses complicated parapneumonic effusions and primary pleural infections, and includes but is not limited to empyema, which refers to collection of pus in the pleural cavity. The incidence of pleural infection in adults has been continuously increasing over the past two decades, particularly in older adults, and most of such patients have comorbidities. Management of pleural infection requires prolonged duration of hospitalization (average 14 days). There are recognized differences in microbial etiology of pleural infection depending on whether the infection was acquired in the community or in a health-care setting. Anaerobic bacteria are acknowledged as a major cause of pleural infection, and thus anaerobic coverage in antibiotic regimens for pleural infection is mandatory. The key components of managing pleural infection are appropriate antimicrobial therapy and chest-tube drainage. In patients who fail medical therapy by manifesting persistent sepsis despite standard measures, surgical intervention to clear the infected space or intrapleural fibrinolytic therapy (in poor surgical candidates) are recommended. Recent studies have explored the role of early intrapleural fibrinolytics or first-line surgery, but due to considerable costs of such interventions and the lack of convincing evidence of improved outcomes with early use, early intervention cannot be recommended, and further evidence is awaited from ongoing studies. Other areas of research include the role of routine molecular testing of infected pleural fluid in improving the rate of identification of causative organisms. Other research topics include the benefit of such interventions as medical thoracoscopy, high-volume pleural irrigation with saline/antiseptic solution, and repeated thoracentesis (as opposed to chest-tube drainage) in reducing morbidity and improving outcomes of pleural infection. This review summarizes current knowledge and practice in managing pleural infection and future research directions.

Indexed as

empyemapleural infectionpneumoniarespiratory infections

Identifiers

PMID34290522
PMCPMC8286963
OpenAlexW3178994031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.